Joe Biden is undergoing a five-week course of radiation and hormone therapy for prostate cancer that was diagnosed in May and had spread to his bones, marking a new phase in his treatment.
A man shares his personal experience with testosterone therapy, highlighting the initial benefits of increased energy and muscle mass, but also the serious risks such as elevated hematocrit and potential heart failure due to high doses and lack of proper medical oversight. He emphasizes the importance of evidence-based dosing, routine monitoring, and cautious use of testosterone, warning that widespread, unregulated use poses significant health dangers.
The U.S. Supreme Court is set to consider whether to allow red states to ban hormone treatments for transgender teens, a decision that could significantly impact transgender rights and healthcare access across the country. This legal battle highlights the ongoing tension between state policies and federal protections for transgender individuals.
A new study presented at The Menopause Society's Annual Meeting reveals that obesity may increase the severity of menopausal symptoms in women and decrease the effectiveness of hormone treatment. The five-year study involving 119 patients found that women with obesity were more likely to experience hot flashes, genitourinary/vulvovaginal symptoms, mood disturbances, and decreased libido. The researchers concluded that menopausal women with obesity had a higher prevalence of menopause symptoms and lower efficacy of hormone treatment. These findings highlight the importance of considering obesity when counseling women on managing their menopause symptoms.